OZURDEX J Code: J7312

Drug & Product Overview

HCPCS Descriptor Injection, dexamethasone, intravitreal implant, 0.1 mg

HCPCS Added Date January 1, 2011

Manufacturer AbbVie

Route of Administration Intravitreal

Generic Status Single-Source; Branded

Dosage Type Single-Dose

Dosage Form Implant

About OZURDEX

Ozurdex is a medication aligned to the HCPCS J Code: J7312 for billing, pricing, and reimbursement purposes in the United States. It is an Ophthalmology drug administered via the intravitreal route and manufactured by AbbVie.

According to CMS Drug Use Information: Drug uses not available

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
00023-3348-07	Ozurdex	Allergan, Inc.	7	0.7 MG

Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

OZURDEX Pricing & Reimbursement

J7312 Private Payer Reimbursement

$204.72 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Historical Graphing and Billing Calculator

per HCPCS unit

As of Q4 2026

OZURDEX CPT Administration Codes

CPT Code	Description
67028	Intravitreal injection of a pharmacologic agent (separate procedure) 67028

JW / JZ modifiers apply

CMS has identified Ozurdex (J7312) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →

OZURDEX Medically Unlikely Edits (MUE)

The most billing units of J7312 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 0.1 mg.

Practitioner Office & Hospital Outpatient

14 units / day

= 1.4 mg per day

MAI 2 · Date of Service Edit: Policy. Absolute per-day limit set by policy or regulation; units above it are not payable, and denials are not appealable on medical-necessity grounds. See all MUE limits →

OZURDEX Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Diabetic macular edema Macular edema following branch retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO) Non-infectious uveitis affecting the posterior segment of the eye

Drug Class

Corticosteroid Hormone Receptor Agonists [MoA]Corticosteroid [EPC]

Frequently Asked Questions

Is there an available Ozurdex billing and coding guide?

Billing and coding information for OZURDEX can be found through Allergan. Visit Here →

Are there any available Ozurdex patient assistance programs?

OZURDEX patient assistance information can be found through Allergan. Visit Here →

Where can I find Ozurdex prescribing information?

OZURDEX prescribing information can be found at the link below: Visit Here →

Where can I find Ozurdex side effect information?

Our team has not yet identified a source of side effects information for OZURDEX. Please check back in a few weeks.

Does billing OZURDEX require JZ/JW wastage modifiers?

CMS has identified OZURDEX(J7312) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. See CMS guidelines on use of the JZ and JW wastage modifiers below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.